Novel Bioenhanced Curcumin With Mesalamine for Induction of Remission in Mild-to-Moderate Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study
J. Clin. Gastroenterol. 2020 Sep 04;[EPub Ahead of Print], R Banerjee, P Pal, A Penmetsa, P Kathi, G Girish, I Goren, DN ReddyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.